Incidence and Risk Factors Identified for Secondary Neoplasms After HSCT for Patients With Sickle Cell Disease
Researchers sought to determine the risk factors for patients with SCD developing a secondary neoplasm after undergoing HSCT.
Researchers sought to determine the risk factors for patients with SCD developing a secondary neoplasm after undergoing HSCT.
Researchers sought to identify factors that could be associated with secondary myeloid neoplasms in patients with aplastic anemia and PNH.
Enjaymo is an immunoglobulin G subclass 4 monoclonal antibody.
Researchers sought to determine whether rivipansel would effectively treat vaso-occlusive crisis in patients with sickle cell disease.
Researchers sought to determine whether care from a multidisciplinary pulmonary clinic would improve health outcomes in patients with SCD.
Researchers sought to determine the rate of adherence to enoxaparin for VTE prophylaxis in hospitalized patients with SCD.
Patients with anemia may know some of the risks associated with the condition, but do they know about potential cancer-related risks? How can health care professionals educate patients on the risks, and what is known about the potential association between newly diagnosed anemia and cancer risk?
More infants in formula-fed versus breastfed group developed iron deficiency, despite having higher mean total daily iron intake.
Researchers reported on treatment of Hodgkin lymphoma in a patient with SCD, utilizing doxorubicin, vinblastine, and dacarbazine.
Researchers sought to address the reported blood shortages for patients with MDS in Europe.